Galapagos NV Profile Avatar - Palmy Investing

Galapagos NV

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of …
Biotechnology
BE, Mechelen [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

Galapagos NV has no lobbying expenses in our database.
FY Quarter Lobby Expense [in mil. $] Filing Report Time
No data
End of GLPGF's Analysis
CIK: 1421876 CUSIP: - LEI: - UEI: -
Secondary Listings